Modeling promising nonmyeloablative conditioning regimens in nonhuman primates

Human Gene Therapy

Volumn 25, Issue 12, 2014, Pages 1013-1022

  Chandrasekaran, Devikha ^a   Nakamoto, Betty ^b   Watts, Korashon L ^a   Kiem, Hans Peter ^a,b   Papayannopoulou, Thalia ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYTOKINE ANTIBODY; GREEN FLUORESCENT PROTEIN; PLERIXAFOR; SR 1; UNCLASSIFIED DRUG; CD34 ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; BURST FORMING UNIT E; COLONY FORMING UNIT; CONTROLLED STUDY; HUMAN; HUMAN CELL; JUVENILE ANIMAL; MACACA NEMESTRINA; NONHUMAN; NONMYELOABLATIVE CONDITIONING; REDUCED INTENSITY CONDITIONING; WHOLE BODY RADIATION; ANIMAL; AUTOTRANSPLANTATION; DISEASE MODEL; GENE THERAPY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LENTIVIRINAE; MACACA; PROCEDURES; TRANSPLANTATION CONDITIONING;

ANIMALIA; PRIMATES;

ANIMALS; ANTIGENS, CD34; DISEASE MODELS, ANIMAL; GENETIC THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LENTIVIRUS; MACACA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84918784096     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.031     Document Type: Article

References (47)

1. Ahmed, F., Ings, S.J., Pizzey, A.R., et al. (2004). Impaired bone marrow homing of cytokine-Activated CD34+ cells in the NOD/SCID model. Blood 103, 2079-2087
2. Aiuti, A., Slavin, S., Aker, M., et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413
3. Andrade, J., Ge, S., Symbatyan, G., et al. (2011). Effects of sublethal irradiation on patterns of engraftment after murine bone marrow transplantation. Biol. Blood Marrow Transplant. 17, 608-619
4. Anurathapan, U., Pakakasama, S., Rujkijyanont, P., et al. (2013). Pretransplant immunosuppression followed by reduced-Toxicity conditioning and stem cell transplantation in high-risk thalassemia: A safe approach to disease control. Biol. Blood Marrow Transplant. 19, 1259-1262
5. Bauer, T.R., Jr., Allen, J.M., Hai, M., et al. (2008). Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat. Med. 14, 93-97
6. Beard, B.C., Mezquita, P., Morris, J.C., and Kiem, H.P. (2006). Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors. Mol. Ther. 14, 212-217
7. Beard, B.C., Trobridge, G.D., Ironside, C., et al. (2010). Efficient and stable MGMT-mediated selection of long-Term repopulating stem cells in nonhuman primates. J. Clin. Invest. 120, 2345-2354
8. Bernardo, M.E., Piras, E., Vacca, A., et al. (2012). Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-Toxicity conditioning regimen based on the use of treosulfan. Blood 120, 473-476
9. Bonig, H., Watts, K., Chang, K.-H., et al. (2009). Concurrent blockade of a-4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization. Stem Cells 27, 836-837
10. Broudy, V.C., Lin, N., Zsebo, K.M., et al. (1992). Isolation and characterization of a monoclonal antibody that recognizes the human c-Kit receptor. Blood 79, 338-346
11. Broxmeyer, H.E., Hoggatt, J., O'Leary, H.A., et al. (2012). Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat. Med. 18, 1786-1796
12. Chen, J., Larochelle, A., Fricker, S., et al. (2006). Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood 107, 3764-3771
13. Czechowicz, A., Bhardwaj, R., Pang, W., et al. (2011). Targeted clearance of human hematopoietic stem cell niches via inhibition of SCF signaling using monoclonal antibody SR-1. Biol. Blood Marrow Transplant. 17, S187-S188
14. Fewkes, N.M., Krauss, A.C., Guimond, M., et al. (2010). Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood 115, 4120-4129
15. Galambrun, C., Pondarre, C., Bertrand, Y., et al. (2013). French multicenter 22-year experience in stem cell transplantation for b-Thalassemia major: Lessons and future directions. Biol. Blood Marrow Transplant. 19, 62-68
16. Gerbaulet, A., Schoedel, K., Goethert, J., et al. (2013). Inducible depletion of hematopoietic stem cells in vivo challenges niche availability as the critical determinant for bone marrow engraftment. Exp. Hematol. 41, S42
17. Gunji, Y., Nakamura, M., Osawa, H., et al. (1993). Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells. Blood 82, 3283-3289
18. Hendrikx, P.J., Martens, C.M., Hagenbeek, A., et al. (1996). Homing of fluorescently labeled murine hematopoietic stem cells. Exp. Hematol. 24, 129-140
19. Hsieh, M.M., Kang, E.M., Fitzhugh, C.D., et al. (2009). Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N. Engl. J. Med. 361, 2309-2317
20. Huhn, R.D., Tisdale, J.F., Agricola, B., et al. (1999). Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning. Hum. Gene Ther. 10, 1783-1790
21. Hussein, A.A., Al-Zaben, A., Ghatasheh, L., et al. (2013). Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Pediatr. Blood Cancer 60, 1345-1349
22. Iannone, R., Casella, J.F., Fuchs, E.J., et al. (2003). Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and b-Thalassemia. Biol. Blood Marrow Transplant. 9, 519-528
23. Jiang, Y., Bonig, H., Ulyanova, T., et al. (2009). On the adaptation of endosteal stem cell niche function in response to stress. Blood 114, 3773-3782
24. King, A., and Shenoy, S. (2014). Evidence-based focused review of the status of hematopoietic stem cell transplantation as treatment for sickle cell disease and thalassemia. Blood 123, 3089-3094
25. Liu, B., Buckley, S.M., Lewis, I.D., et al. (2003). Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95. Exp. Hematol. 31, 824-832
26. Lutzko, C., Kruth, S., Abrams-Ogg, A.C., et al. (1999). Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine a-l-iduronidase deficiency. Blood 93, 1895-1905
27. Mazurier, F., Gan, O.I., McKenzie, J.L., et al. (2004). Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103, 545-552
28. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., et al. (2001). Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-Tumor effects. Blood 97, 3390-3400
29. Neta, R., Williams, D., Selzer, F., and Abrams, J. (1993). Inhibition of c-Kit ligand/steel factor by antibodies reduces survival of lethally irradiated mice. Blood 81, 324-327
30. Ogawa, M., Matsuzaki, Y., Nishikawa, S., et al. (1991). Expression and function of c-Kit in hemopoietic progenitor cells. J. Exp. Med. 174, 63-71
31. Porter, R.L., Georger, M.A., and Calvi, L.M. (2011). Prostaglandin E2 inhibits apoptosis in hematopoietic stem and progenitor cells and enhances their survival following sublethal radiation injury. Abstract 3401 presented at the 53rd ASH Annual Meeting and Exposition, December 10-13, 2011
32. Porter, R.L., Georger, M.A., Bromberg, O., et al. (2013). Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells 31, 372-383
33. Rohrabaugh, S.L., Campbell, T.B., Hangoc, G., and Broxmeyer, H.E. (2011). Ex vivo rapamycin treatment of human cord blood CD34+ cells enhances their engraftment of NSG mice. Blood Cells Mol. Dis. 46, 318-320
34. Rosenzweig, M., Macvittie, T.J., Harper, D., et al. (1999). Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood 94, 2271-2286
35. Rosenzweig, M., Connole, M., Glickman, R., et al. (2001). Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34+ hematopoietic cells. Blood 97, 1951-1959
36. Sadelain, M.W., Green, D.R., and Wegmann, T.G. (1990). Host natural suppressor activity regulates hemopoietic engraftment kinetics in antibody-conditioned recipient mice. J. Immunol. 144, 1729-1736
37. Sato, T., Ikeda, M., Yotsumoto, S., et al. (2013). Novel interferon-based pre-Transplantation conditioning in the treatment of a congenital metabolic disorder. Blood 121, 3267-3273
38. Shin, J.Y., Hu, W., Naramura, M., (2014). High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. J. Exp. Med. 211, 217-231
39. Storb, R.F., Champlin, R., Riddell, S.R., et al. (2001). Nonmyeloablative transplants for malignant disease. Hematol. Am. Soc. Hematol. Educ. Program 2001, 375-391
40. Szilvassy, S.J., Meyerrose, T.E., Ragland, P.L., and Grimes, B. (2001). Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of b1 integrin. Exp. Hematol. 29, 1494-1502
41. Tolar, J., Mehta, P.A., and Walters, M.C. (2012). Hematopoietic cell transplantation for nonmalignant disorders. Biol. Blood Marrow Transplant. 18(1 Suppl.), S166-S171
42. Trobridge, G.D., Beard, B.C., Gooch, C., et al. (2008). Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111, 5537-5543
43. Uchida, N., Weitzel, R.P., Evans, M.E., et al. (2014). Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model. Gene Ther. 21, 148-157
44. van Os, R., Dawes, D., Mislow, J.M., et al. (1997). Host conditioning with 5-fluorouracil and Kit-ligand to provide for long-Term bone marrow engraftment. Blood 89, 2376-2383
45. Verovskaya, E., Broekhuis, M.J., Zwart, E., et al. (2014). Asymmetry in skeletal distribution of mouse hematopoietic stem cell clones and their equilibration by mobilizing cytokines. J. Exp. Med. 211, 487-497
46. Xue, X., Pech, N.K., Shelley, W.C., et al. (2010). Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice. Blood 116, 5419-5422
47. Yong, K.L., Fahey, A., Pizzey, A., and Linch, D.C. (2002). Influence of cell cycling and cell division on transendothelial migration of CD34+ cells. Br. J. Haematol. 119, 500-509